You are here

Researchers and Physicians

Getting Real with Clinical Trials

Most studies of new treatments don't reflect the diversity of people in the real world. That's a problem. THE NEXT TIME YOU TAKE A MEDICATION, CONSIDER THIS: It’s available because it was shown to be safe and effective in clinical trials. In these controlled studies, researchers give a new...

Liquid Biopsies Smooth The Way For Personalized Medicine

What if just two vials of your blood could tell doctors which cancer treatment would work best for you? By design, some of the newest and most exciting cancer treatments don’t work for everybody. Instead, they target tumors that have a specific genetic mutation or characteristic. A treatment like...

Cancer Prevention: Making It Easy Like Sunday Morning

GILDA SUITER, 54, OF DURHAM, NORTH CAROLINA, struggled with gastroesophageal reflux disease, known as acid reflux, for several years. Two years ago, her doctor recommended that she take a urea breath test—a non-invasive diagnostic test to detect a common bacterium called Helicobacter pylori (H...

#MyDukeCancerStory: A Fair Shake

When Nadine Barrett, PhD , was 15, she and her mother traveled from their home in Wimbledon, England to New York City and ended up staying; making a home in Brooklyn. They were immigrants seeking “new opportunities to advance their education and career,” Barrett said, and undocumented. “We lived in...

#MyDukeCancerStory: A Champion For The Disadvantaged & The Elimination Of Cancer

As a boy growing up in Schenectady, New York, Steven Patierno, PhD, could often be found out in the woods performing surgery on frogs, when he wasn’t playing sandlot soccer or a local, slightly more “aggressive” version of capture the flag. “I always knew I wanted to be a scientist, even before I...

Emerging Options For Gynecologic Cancers

Women with gynecological cancer have more treatment options than ever. Currently, Duke has 15 clinical trials open for women with gynecologic cancers, including ovarian, endometrial, or cervical cancer.

Stopping A Stealth Disease

Survivors, family members, and researchers have been working together for more than a decade to detect ovarian cancer earlier and educate women about its signs.

Machine Learning

For women with ductal carcinoma in situ, Duke researchers are working to use “machine learning” to reduce unnecessary follow-up breast imaging and offer some women less-invasive treatment options.

Gauging Risk

Led by breast surgeon and Assistant Professor of Surgery Jennifer Plichta, MD, MS, Duke’s Breast Risk Assessment Clinic helps women learn about their individual likelihood for developing the disease.

Pages